Your Health Plan:
Your Health Plan:
Not SelectedATELVIA (risedronate sodium hemi-pentahydrate and risedronate sodium monohydrate) is a brand-name prescription drug for treatment of Osteoporosis, Postmenopausal. ATELVIA is a combination of bisphosphonate and bisphosphonate. It is available in the form of oral tablet.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $305-360.
No saving program is found for ATELVIA.
Other alternatives to ATELVIA may include: